- Home
- IVVD vs YSXT Comparison
IVVD vs YSXT Comparison
Compare IVVD & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVVD | YSXT |
|---|---|---|
| Founded | 2020 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 437.1M | 24.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | IVVD | YSXT |
|---|---|---|
| Price | $1.83 | $1.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.75 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 352.5K |
| Earning Date | 06-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 79.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $53,426,000.00 | N/A |
| Revenue This Year | $143.48 | N/A |
| Revenue Next Year | $25.40 | N/A |
| P/E Ratio | ★ N/A | $5.57 |
| Revenue Growth | ★ 110.47 | N/A |
| 52 Week Low | $0.46 | $1.03 |
| 52 Week High | $3.07 | $9.90 |
Technical Indicators
Market Signals| Indicator | IVVD | YSXT |
|---|---|---|
| Relative Strength Index (RSI) | 51.65 | 54.66 |
| Support Level | $1.41 | $1.08 |
| Resistance Level | $2.01 | $1.47 |
| Average True Range (ATR) | 0.11 | 0.15 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 57.32 | 45.83 |
Price Performance
Historical ComparisonAbout IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.